Advertisement
Advertisement
TMDX
TransMedics Group, Inc. Common Stock
67.20
USDSponsored
-0.63
-0.93%
May 29, 16:00 UTC -4
Closed
After-Market
67.31
+0.11
+0.16%
TMDX Earnings Reports
Positive Surprise Ratio
TMDX beat 18 of 29 last estimates.
62%
Next Report
Date of Next Report
Jul 28, 2026
Estimate for Q2 26 (Revenue/ EPS)
$188.15M
/$0.56
Implied change from Q1 26 (Revenue/ EPS)
+8.17%
/+86.67%
Implied change from Q2 25 (Revenue/ EPS)
+19.56%
/-39.13%
TransMedics Group, Inc. Common Stock earnings per share and revenue
On May 05, 2026, TMDX reported earnings of 0.30 USD per share (EPS) for Q1 26, missing the estimate of 0.62 USD, resulting in a -52.00% surprise. Revenue reached 173.93 million, compared to an expected 176.09 million, with a -1.22% difference. The market reacted with a -23.19% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 12 analysts forecast an EPS of 0.56 USD, with revenue projected to reach 188.15 million USD, implying an increase of 86.67% EPS, and increase of 8.17% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Alpha Tau Medical Ltd. Ordinary Shares
Report Date
May 18, 2026 For Q1 26
Estimate
-$0.12
Actual
-$0.26
Surprise
-106.35%
Mesa Laboratories Inc
Report Date
May 27, 2026 For Q4 26
Estimate
$0.34
Actual
$2.76
Surprise
+695.85%
ENvue Medical, Inc. Common Stock
Report Date
May 18, 2026 For Q1 26
Estimate
-Actual
-$6.88
Surprise
-
FAQ
What were TransMedics Group, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, TransMedics Group, Inc. Common Stock reported EPS of $0.30, missing estimates by -52%, and revenue of $173.93M, -1.22% below expectations.
How did the market react to TransMedics Group, Inc. Common Stock's Q1 2026 earnings?
The stock price moved down -23.19%, changed from $94.93 before the earnings release to $72.92 the day after.
When is TransMedics Group, Inc. Common Stock expected to report next?
The next earning report is scheduled for Jul 28, 2026.
What are the forecasts for TransMedics Group, Inc. Common Stock's next earnings report?
Based on 12
analysts, TransMedics Group, Inc. Common Stock is expected to report EPS of $0.56 and revenue of $188.15M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement